Live Breaking News & Updates on Guillaume Renondin
Stay updated with breaking news from Guillaume renondin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pixium Vision receives HealthTech Award for Prima System at the MedTech Forum Best Product/Deal for its bionic vision Prima System. The award, presented at the MedTech Forum 2021, recognizes the most promising game changers developing emerging technologies for healthcare in Europe, and is organized by the NOBEL Projectand hosted by the MedTech Forum.
HealthTech Lloyd Diamond, Chief Executive Officer of Pixium Vision . The Prima System has demonstrated its potential to make a significant improvement to the quality of life of patients with dry AMD and this award recognizes its capacity to improve vision. I would like to thank the entire Pixium Vision team and our collaborators for their dedication in developing the Prima System and progressing it through clinical trials and towards patients in desperate need of ....
Lloyd Diamond, Chief Executive Officer of Pixium Vision . “The Prima System has demonstrated its potential to make a significant improvement to the quality of life of patients with dry AMD and this award recognizes its capacity to improve vision. I would like to thank the entire Pixium Vision team and our collaborators for their dedication in developing the Prima System and progressing it through clinical trials and towards patients in desperate need of treatment.” The Prima System, a photovoltaic substitute of photoreceptors providing simultaneous use of the central prosthetic and peripheral natural vision in atrophic dry age-related macular degeneration (AMD), is being studied in the pivotal PRIMAvera trial. The study was initiated in Q4 2020 and aims to confirm the safety and the benefits provided by the Prima System and is the last clinical step before seeking market approval in Europe. ....
Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. Paris, 16 April 2021 - 6:00 p.m. CEST - Pixium Vision (Euronext Growth Paris - FR0011950641 - ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, announces a cash position of €9.7 million at 31 March 2021 and reports on its key developments. Statement of cash flows summary In thousands of € 10,566.0 (818.4) (3,639.4) (10.8) 2,831.8 9,747.6 4,830.6 Net cash outflow from operating activities in the first three months of 2021 totalled €3.6 million, compared to €2.5 million one year earlier. The increased cash outflow was primarily due to the launch of the PRIMAvera clinical trial i ....
Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.